Trademark Overview
On Thursday, November 13, 2025, a trademark application was filed for SEQUENCIO with the United States Patent and Trademark Office. The USPTO has given the SEQUENCIO trademark a serial number of 99494302. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Monday, March 23, 2026. This trademark is owned by Sequencio Therapeutics Company Limited. The SEQUENCIO trademark is filed in the Pharmaceutical Products category with the following description:
Vaccines; pharmaceutical preparations for the prevention and treatment of cancer; biological preparations for treatment of cancer; human vaccine preparations; anti-cancer preparations; anti-cancer agents; drugs for the treatment of cancer; drugs for medical purposes; medicines for human purposes; vaccines against cancer; anti-cancer drugs; therapeutic cancer vaccines; immunotherapeutic agent; biological preparations for the treatment of premalignant disease to prevent malignant transformation; biological preparations for the treatment of premalignant conditions